Trials / Completed
CompletedNCT05037981
Effect of Early Systemic Stabilization Therapy on Recent Onset Vitiligo
Evaluation of Early Systemic Stabilization Therapy on Recent Onset Localized Non-segmental Vitiligo
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 6 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Vitiligo is a distressing disorder of depigmentation. In spite of multiple successful therapeutic regimens, disease relapse remains a challenge to patients and physicians. Most guidelines consider systemic treatments only in rapidly progressive disease with wider surface areas. This delay in halting the immune attack, may give the chance for further disease progression as well as establishment of resident memory T cell population predisposing to future disease relapses. The aim of this study was to assess the ability of early systemic therapy of localized (\<2% BSA), recent onset (\<6 months) vitiligo to control disease activity and minimize the possibility of recurrence.
Conditions
Timeline
- Start date
- 2015-10-10
- Primary completion
- 2021-08-10
- Completion
- 2021-08-20
- First posted
- 2021-09-08
- Last updated
- 2021-09-08
Source: ClinicalTrials.gov record NCT05037981. Inclusion in this directory is not an endorsement.